Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs
Submitted: 1 August 2020
Accepted: 15 February 2021
Published: 19 April 2021
Accepted: 15 February 2021
Abstract Views: 3476
PDF: 487
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S. Antonelli, G.D. Sebastiani, Polyarticular heterotopic ossification complicating drug induced coma , Reumatismo: Vol. 54 No. 1 (2002)
- P. Lazzarin, E. Presotto, A. Polo, Churg-Strauss syndrome presenting as polymiositis: report of a case , Reumatismo: Vol. 61 No. 2 (2009)
- M. Rampudda, P. Marson, G. Pasero, The main stages in the history of systemic lupus erythematosus , Reumatismo: Vol. 61 No. 2 (2009)
- A.A. Conti, D. Lippi, G.F. Gensini, The historical evolution of the concept of apoptosis in rheumatic diseases , Reumatismo: Vol. 57 No. 1 (2005)
- G. Minisola, Biotechnological innovation to the benefit of the rheumatic patient , Reumatismo: Vol. 63 No. 3 (2011)
- M. Rossini, P. Piscitelli, F. Fitto, P. Camboa, A. Angeli, G. Guida, S. Adami, Incidence and socioeconomic burden of hip fractures in Italy , Reumatismo: Vol. 57 No. 2 (2005)
- F. Laghi Pasini, P.L. Capecchi, F. Bellisai, P.E. Lazzerini, M. Galeazzi, Indications for intra-venous immunoglobulin treatment in rheumatic diseases , Reumatismo: Vol. 55 No. 4 (2003)
- A. Donvito, A. Crisanti, F. Bellisai, M. Galeazzi, Combined interferon a2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial - Reply , Reumatismo: Vol. 57 No. 2 (2005)
- A. Lo Monaco, F. Lanza, M. Dabusti, M. Padovan, R. La Corte, G. Castoldi, F. Trotta, Autologous stem cell transplantation in patient with diffuse systemic sclerosis , Reumatismo: Vol. 54 No. 4 (2002)
- A. Corrado, F.P. Cantatore, The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects , Reumatismo: Vol. 57 No. 3 (2005)
<< < 50 51 52 53 54 55 56 57 58 59 > >>
You may also start an advanced similarity search for this article.